Preparation method and application of N-heterocyclic carbene catalyzed cyclopropane skeleton-containing ketene compound
A technology for cyclopropane and compounds, which is applied in the field of preparation and application of cyclopropane skeleton-containing enone compounds catalyzed by azacyclic carbene, and achieves excellent yield, high diastereoselectivity, and good substrate universality
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation Embodiment 1
[0026] Preparation Example 1
[0027] Preparation of N-((Z)-3-((1R,2R)-2-benzoylcyclopropyl)-3-oxo-1-phenylprop-1-en-1-yl)-4-methanol Benzenesulfonamide (I 3 ):
[0028]
[0029] Preparation implementation method and conditions are as follows:
[0030] Weigh 0.20mmol substituted 1-cyclopropyl formaldehyde 1, 0.1mmol substituted sulfonimide 2, 0.02mmol azacyclic carbene catalyst F (9.6mg), 0.12mmol cesium carbonate (39.1mg), 0.02mmol trifluoromethane Zinc sulfonate (7.2mg), 100mg Molecular sieves and 0.20 mmol DQ oxidant (81.7 mg) were added to a 4.0 mL reaction bottle equipped with a magnetic stirrer, 2.0 mL of dichloromethane was added, the reaction wall was shaken gently to mix well, and the reaction was stirred at 35 degrees Celsius for 17 hours. Spin dry after the completion of TLC monitoring reaction, dry loading, separate by column chromatography (eluent polar sherwood oil: ethyl acetate=10:1), obtain target compound I 3 , and calculate the corresponding yield a...
preparation Embodiment 2
[0036] Preparation Example 2
[0037] Substituent R 1 4-OCH 3 -Ph, R 2 For Ph, preparation implementation method and condition are with general embodiment 1;
[0038] N-((Z)-3-((1R,2R)-2-(4-methoxybenzoyl)cyclopropyl)-3-oxo-1-phenylprop-1-ene-1- Base) -4-methylbenzenesulfonamide (I 3b )
[0039]
[0040] 1 H NMR (400MHz, CDCl 3 )δ12.19(s,1H),8.03–7.98(m,2H),7.46–7.40(m,1H),7.36(d,J=8.3Hz,2H),7.33–7.25(m,4H),7.15 (d,J=8.1Hz,2H),7.00–6.95(m,2H),5.72(s,1H),3.89(s,3H),3.27–3.20 (m,1H),2.52(td,J=7.3 ,3.7Hz,1H),2.36(s,3H),1.68–1.61(m,2H).
[0041] 13 C NMR (101MHz, CDCl 3)δ198.6, 195.5, 163.9, 155.3, 144.2, 136.7, 133.4, 130.8, 130.6, 130.0, 129.4, 129.0, 127.9, 127.5, 113.9, 108.5, 55.6, 32.8, 28.4, 21.6, 20.1.
preparation Embodiment 3
[0043] Preparation Example 3
[0044] Substituent R 1 4-CH 3 -Ph,R 2 For Ph, the preparation method and conditions are the same as in General Example 1; N-((Z)-3-((1R,2R)-2-(4-methylbenzoyl)cyclopropyl)-3-oxo -1-phenylprop-1-en-1-yl)benzenesulfonamide (I 3c )
[0045]
[0046] 1 H NMR (400MHz, CDCl 3 )δ12.18(s,1H), 7.95–7.87(m,2H),7.46–7.40(m,1H),7.38–7.33(m,2H),7.33–7.25(m,6H),7.15(d, J=8.2Hz,2H),5.72(s,1H),3.29–3.22(m,1H), 2.57–2.50(m,1H),2.43(s,3H),2.35(s,3H),1.68–1.62 (m,2H).
[0047] 13 C NMR (101MHz, CDCl 3 )δ198.5, 196.8, 155.4, 144.4, 144.2, 136.7, 134.5, 133.4, 130.8, 129.4, 129.4, 129.0, 128.4, 127.9, 127.5, 108.5, 32.9, 28.6, 21.7, 21.6, 20.2.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


